- Report
- August 2025
- 189 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- August 2025
- 247 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- August 2025
- 182 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- August 2025
- 194 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- December 2024
- 200 Pages
Global
From €3316EUR$3,750USD£2,862GBP
- Report
- March 2025
- 150 Pages
Global
From €3404EUR$3,850USD£2,939GBP
€4288EUR$4,850USD£3,702GBP
- Report
- June 2025
- 400 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- May 2025
- 75 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- October 2024
- 138 Pages
Global
From €3537EUR$4,000USD£3,053GBP
- Report
- April 2025
Global
From €6631EUR$7,500USD£5,725GBP
- Report
- April 2025
Global
From €6631EUR$7,500USD£5,725GBP
- Report
- April 2025
- 125 Pages
Global
From €4288EUR$4,850USD£3,702GBP
- Report
- June 2025
- 250 Pages
United States
From €2466EUR$2,789USD£2,129GBP
- Report
- June 2025
- 300 Pages
Europe
From €3421EUR$3,869USD£2,953GBP
- Report
- June 2025
- 300 Pages
North America
From €3421EUR$3,869USD£2,953GBP
- Report
- June 2024
- 51 Pages
China
From €973EUR$1,100USD£840GBP
- Report
- September 2018
- 233 Pages
Global
From €2829EUR$3,200USD£2,443GBP
€3537EUR$4,000USD£3,053GBP
- Report
- February 2021
- 144 Pages
Global
From €2431EUR$2,750USD£2,099GBP
- Report
- July 2025
- 200 Pages
Japan
From €2202EUR$2,490USD£1,901GBP
From €3095EUR$3,500USD£2,672GBP

The Transcatheter Mitral Valve (TMV) is a type of cardiovascular device used to treat mitral valve regurgitation, a condition in which the mitral valve does not close properly, allowing blood to flow backward into the left atrium. TMV is a minimally invasive procedure that involves the insertion of a prosthetic valve into the heart through a catheter. This procedure is an alternative to open-heart surgery, which is more invasive and carries a higher risk of complications.
TMV is a rapidly growing market, with a number of companies developing and marketing products. These companies are focused on improving the safety and efficacy of TMV procedures, as well as expanding the range of patients who can benefit from the procedure. Companies in the TMV market include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and Neovasc. Show Less Read more